Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

10.0%

1 terminated/withdrawn out of 10 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

Phase 1
2(40.0%)
N/A
2(40.0%)
Phase 2
1(20.0%)
5Total
Phase 1(2)
N/A(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials
NCT07455630Completed

Cardiac Function and Biomarkers in Patients With Obesity and Overweight

Role: lead

NCT07045714Recruiting

Bilateral Lumbar Decompression Via Uniportal Endoscopic Laminotomy in Patients With Lumbar Spinal Stenosis: Multicentric Case Series

Role: lead

NCT06886802Recruiting

Multicentric Case Series of Uniportal Endoscopic Posterior Cervical Decompression for Cervical Spinal Stenosis

Role: lead

NCT07157332Not Yet Recruiting

Iron Metabolism in Obesity

Role: lead

NCT05888454Not ApplicableRecruiting

Integrative Group Program for Type 2 Diabetes Mellitus (T2DM)

Role: lead

NCT01819376Not ApplicableCompleted

Use of Facebook as a Motivating Factor in a Weight-reduction Program for Obese and Overweight Adolescents

Role: lead

NCT04514302Phase 1Completed

Safety and Efficacy of Anti-SARS-CoV-2 Equine Antibody F(ab')2 Fragments (INOSARS) for Adult Patients With Mild COVID-19

Role: lead

NCT04333355Phase 1Terminated

Safety in Convalescent Plasma Transfusion to COVID-19

Role: lead

NCT04388410Phase 2Unknown

Safety and Efficacy of Convalescent Plasma Transfusion for Patients With COVID-19

Role: collaborator

NCT02075918Completed

Integrated Approaches for Identifying Molecular Targets in Alcoholic Hepatitis

Role: collaborator

All 10 trials loaded